Cambridge Investment Research Advisors
ALIM

Cambridge Investment Research Advisors’s Alimera Sciences ALIM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,207
Closed -$10K – 2483
2019
Q3 		$10K Hold
1,207
– – ﹤0.01% 2332
2019
Q2 		$16K Hold
1,207
– – ﹤0.01% 2184
2019
Q1 		$19K Sell
1,207
-380
-24% -$5.78K ﹤0.01% 2255
2018
Q4 		$17K Hold
1,587
– – ﹤0.01% 2128
2018
Q3 		$23K Hold
1,587
– – ﹤0.01% 2222
2018
Q2 		$23K Hold
1,587
– – ﹤0.01% 2188
2018
Q1 		$25K Hold
1,587
– – ﹤0.01% 2126
2017
Q4 		$32K Buy
+1,587
New +$31K ﹤0.01% 2080

Other funds holding ALIM

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Cambridge Investment Research Advisors's ALIM Position: Q4 2019 in Review

Cambridge Investment Research Advisors sold out of Alimera Sciences (ALIM) in Q4 2019, closing a stake of 1,207 shares — an estimated $10K sold.

Cambridge Investment Research Advisors first reported a position in ALIM in Q4 2017 and held it in 8 quarters. The position peaked at $32K in Q4 2017. 22 funds tracked by Wall St. Rank hold ALIM as of Q4 2019.

  • Cambridge Investment Research Advisors reported no remaining Alimera Sciences position as of Q4 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,207 Alimera Sciences shares in Q4 2019, an estimated $10K.
  • Cambridge Investment Research Advisors first reported a position in Alimera Sciences in Q4 2017 and held it in 8 quarters.
  • Cambridge Investment Research Advisors's Alimera Sciences position peaked at $32K in Q4 2017.
  • 22 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.